GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol

GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol

Abstract Background The burden of opioid use disorder (OUD) has been increasing in North America. Administration of medication-assisted treatments (MATs) for OUD on an individual-dose basis has been shown to affect patient responses to treatment, proving to be, on occasion, dangerous. A genetic basi...

Full description

Bibliographic Details
Main Authors: Caroul Chawar, Alannah Hillmer, Stephanie Sanger, Alessia D’Elia, Balpreet Panesar, Lucy Guan, Dave Xiaofei Xie, Nandini Bansal, Aamna Abdullah, Flavio Kapczinski, Guillaume Pare, Lehana Thabane, Zainab Samaan
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Systematic Reviews
Subjects:
Genome-wide association
Medication-assisted treatment
Opioid use
Treatment response
SNP
Pharmacogenetics
Online Access:http://link.springer.com/article/10.1186/s13643-020-01461-z

Internet

http://link.springer.com/article/10.1186/s13643-020-01461-z

Similar Items